Cardiac sarcoidosis;Sarcoïdose cardiaque

Revue des Maladies Respiratoires

Volumn 20, Issue 6 III, 2003, Pages

  Aubart, F ^a   Diebold, B ^b   Dhote, R ^a   Weinmann, P ^a   Valeyre, Dominique ^a  

^a AVICENNE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPYRIDAMOLE; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SPIRONOLACTONE;

CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART DISEASE; HEART SCINTISCANNING; HOLTER MONITORING; HUMAN; PATHOGENESIS; SARCOIDOSIS; CARDIOMYOPATHY; REVIEW;

CARDIOMYOPATHIES; HUMANS; SARCOIDOSIS;

EID: 1942516974     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Fleming HA: Sarcoid Heart Disease. Brit Heart J 1974; 36: 54-68.
2. Mitchell DN, du Bois RM, Oldershaw PJ: Cardiac sarcoidosis. BMJ 1997; 314: 320.
3. Silverman KJ, Hutchins GK, Bukley BH: Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-11.
4. Roberts WC, McAllister HA, Ferrans V: Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. Am J Med 1977; 63: 86-108.
5. Matsui Y: Clinicopathological study on fatal myocardial sarcoidosis. Ann NY Acad Science 1976; 278: 455-69.
6. Lewin RF, Mor R, Spitzer S, Arditti A, Hellman C, Agmon J: Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985; 110: 116-22.
7. Fahy GJ, Marwick T, McCreery CJ, Quigley PJ, Maurer BJ: Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996; 109: 62-6.
8. Le Guludec D, Menad F, Faraggi M, Weinmann P, Battesti JP, Valeyre D: Myocardial sarcoidosis: clinical value of technetium 99 m versus stamibi tomoscintigraphy. Chest 1994, 106: 1675-82.
9. Tellier P, Paycha F, Antony I, Nintenberg A, Valeyre D, Foult JM, Battesti JP: Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988; 85: 189-93.
10. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, Legmann P: Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002; 122: 1895-901.
11. Shimada T, Shimada K, Sakane T, Ochiai K, Tsukihashi H, Fukui M, Inoue S, Katoh H, Murakami Y, Ishibashi Y, Maruyama R: Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110: 520-7.
12. Uemura A, Morinoto S, Hiramitsu S, Kato Y, Ito T, Ishibida H: Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299-302.
13. Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT: A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 2003; 41: 322-9.
14. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, Izumi T, Sekiguchi M, Central Japan Heart Study Group: Prognosis determinants of long term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.
15. Valantine HA, Tazelaar HD, Macoviak J, Mullin AV, Hunt SA, Fowler MB, Billingham ME, Schroeder JS: Cardiac sarcoidosis: Response to steroids and transplantation. J Heart Transplant 1987; 6: 244-50.